Sökning: onr:"swepub:oai:gup.ub.gu.se/317777" > Reactive astroglios...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05158naa a2200745 4500 | |
001 | oai:gup.ub.gu.se/317777 | |
003 | SwePub | |
008 | 240910s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3177772 URI |
024 | 7 | a https://doi.org/10.1007/s00259-022-05897-42 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Salvado, G.4 aut |
245 | 1 0 | a Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum |
264 | c 2022-07-18 | |
264 | 1 | b Springer Science and Business Media LLC,c 2022 |
520 | a Purpose Glial activation is one of the earliest mechanisms to be altered in Alzheimer's disease (AD). Glial fibrillary acidic protein (GFAP) relates to reactive astrogliosis and can be measured in both cerebrospinal fluid (CSF) and blood. Plasma GFAP has been suggested to become altered earlier in AD than its CSF counterpart. Although astrocytes consume approximately half of the glucose-derived energy in the brain, the relationship between reactive astrogliosis and cerebral glucose metabolism is poorly understood. Here, we aimed to investigate the association between fluorodeoxyglucose ([F-18]FDG) uptake and reactive astrogliosis, by means of GFAP quantified in both plasma and CSF for the same participants. Methods We included 314 cognitively unimpaired participants from the ALFA + cohort, 112 of whom were amyloid-beta (A beta) positive. Associations between GFAP markers and [F-18]FDG uptake were studied. We also investigated whether these associations were modified by A beta and tau status (AT stages). Results Plasma GFAP was positively associated with glucose consumption in the whole brain, while CSF GFAP associations with [F-18]FDG uptake were only observed in specific smaller areas like temporal pole and superior temporal lobe. These associations persisted when accounting for biomarkers of A beta pathology but became negative in A beta-positive and tau-positive participants (A + T +) in similar areas of AD-related hypometabolism. Conclusions Higher astrocytic reactivity, probably in response to early AD pathological changes, is related to higher glucose consumption. With the onset of tau pathology, the observed uncoupling between astrocytic biomarkers and glucose consumption might be indicative of a failure to sustain the higher energetic demands required by reactive astrocytes. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Radiologi och bildbehandling0 (SwePub)302082 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Radiology, Nuclear Medicine and Medical Imaging0 (SwePub)302082 hsv//eng |
653 | a Glia | |
653 | a Gliosis | |
653 | a Astroglia | |
653 | a Reactive astrocyte | |
653 | a Glucose metabolism | |
653 | a Glucose consumption | |
653 | a energy-metabolism | |
653 | a amyloid-pet | |
653 | a brain | |
653 | a astrocytes | |
653 | a disease | |
653 | a plasma | |
653 | a neuroinflammation | |
653 | a neurons | |
653 | a protein | |
653 | a signal | |
653 | a Radiology | |
653 | a Nuclear Medicine & Medical Imaging | |
700 | 1 | a Mila-Aloma, M.4 aut |
700 | 1 | a Shekari, M.4 aut |
700 | 1 | a Ashton, Nicholas J.u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Wallenberg Centre for Molecular and Translational Medicine,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xashtn |
700 | 1 | a Operto, G.4 aut |
700 | 1 | a Falcon, C.4 aut |
700 | 1 | a Cacciaglia, R.4 aut |
700 | 1 | a Minguillon, C.4 aut |
700 | 1 | a Fauria, K.4 aut |
700 | 1 | a Ninerola-Baizan, A.4 aut |
700 | 1 | a Perissinotti, A.4 aut |
700 | 1 | a Lessa Benedet, Andréau Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xlesan |
700 | 1 | a Kollmorgen, G.4 aut |
700 | 1 | a Suridjan, I.4 aut |
700 | 1 | a Wild, N.4 aut |
700 | 1 | a Molinuevo, J. L.4 aut |
700 | 1 | a Zetterberg, Henrik,d 19734 aut |
700 | 1 | a Blennow, Kaj,d 19584 aut |
700 | 1 | a Suarez-Calvet, M.4 aut |
700 | 1 | a Gispert, J. D.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi4 org |
773 | 0 | t European Journal of Nuclear Medicine and Molecular Imagingd : Springer Science and Business Media LLCg 49, s. 4567-4579q 49<4567-4579x 1619-7070x 1619-7089 |
856 | 4 8 | u https://gup.ub.gu.se/publication/317777 |
856 | 4 8 | u https://doi.org/10.1007/s00259-022-05897-4 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy